We are live on ! Find out more
DXR icon

Daxor
DXR

6 hedge funds and large institutions have $1.03M invested in Daxor in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

0.95% less ownership

Funds ownership: 3.21%2.26% (-0.95%)

32% less capital invested

Capital invested by funds: $1.51M → $1.03M (-$483K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$4.74K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$407K
2
Renaissance Technologies
Renaissance Technologies
New York
-$17.6K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$534K
Renaissance Technologies
2
Renaissance Technologies
New York
$246K -$17.6K -1,600 -7%
SM
3
Sabby Management
Florida
$237K -$407K -36,928 -64%
UBS Group
4
UBS Group
Switzerland
$7K +$4.74K +430 +198%
Wells Fargo
5
Wells Fargo
California
$3K
Morgan Stanley
6
Morgan Stanley
New York
$2K

DXR Hedge Fund Activity: Q4 2021 in Review

6 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q4 2021, worth a combined $1.03M — down 32% from $1.51M a quarter earlier.

Fund positioning in DXR was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was UBS Group, adding an estimated $4.74K. The largest seller was Sabby Management, cutting an estimated $407K.

  • 6 institutional investors held Daxor (DXR) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $1.03M of Daxor stock for Q4 2021, down 32% quarter-over-quarter.
  • 0 funds opened new Daxor positions in Q4 2021 and 0 closed out.
  • The largest Daxor buyer in Q4 2021 was UBS Group, an estimated $4.74K added.
  • The largest Daxor seller in Q4 2021 was Sabby Management, an estimated $407K sold.

Based on aggregated 13F filings for Q4 2021.